ARYA Sciences Acquisition Corp IV (ARYD) Stock
ARYA Sciences Acquisition Corp IV currently lacks substantial ongoing business activities. Its primary objective is to finalize a strategic business combination, which may take the form of a merger, capital stock exchange, asset acquisition, stock purchase, or corporate reorganization, involving one or more other enterprises.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About ARYA Sciences Acquisition Corp IV
ARYA Sciences Acquisition Corp IV currently lacks substantial ongoing business activities. Its primary objective is to finalize a strategic business combination, which may take the form of a merger, capital stock exchange, asset acquisition, stock purchase, or corporate reorganization, involving one or more other enterprises. This company was founded in 2020 and is headquartered in New York, New York.
ARYA Sciences Acquisition Corp IV is headquartered in US.
ARYA Sciences Acquisition Corp IV (ARYD) stock trades at $6.64 with a market capitalization of $50.04M. The stock is valued at a price-to-earnings (P/E) ratio of -30.18, price-to-book of 2.54, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $4.00 and $11.57, and currently trades 42.6% below its 52-week high.
On profitability, ARYA Sciences Acquisition Corp IV generates a return on equity (ROE) of -2.53%, return on capital employed of -16.79%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.perceptivelife.com/arya4